Intra-Cellular Therapies to Present at the SVB Leerink 10th Annual Global Healthcare Conference
February 19 2021 - 8:00AM
Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a
biopharmaceutical company focused on the development and
commercialization of therapeutics for central nervous system (CNS)
disorders, today announced that Sharon Mates, Ph.D., Chief
Executive Officer and Chairman, is scheduled to present at the SVB
Leerink 10th Annual Global Healthcare Conference on Friday,
February 26, 2021 at 10:00 am ET.
The live and archived webcast can be accessed under "Events
& Presentations" in the Investor Relations section of the
Company's website at www.intracellulartherapies.com. Please
log in approximately 5-10 minutes prior to the event to register
and to download and install any necessary software.
About Intra-Cellular
TherapiesIntra-Cellular Therapies is a
biopharmaceutical company founded on Nobel prize-winning
research that allows us to understand how therapies affect the
inner-workings of cells in the body. The company leverages this
intracellular approach to develop innovative treatments for people
living with complex psychiatric and neurologic diseases.
CONTACT:Intra-Cellular Therapies, Inc.Juan
Sanchez, M.D.Vice President, Corporate Communications and Investor
Relations646-440-9333
Burns McClellan, Inc.Lisa BurnsJohn
Grimaldijgrimaldi@burnsmc.com212-213-0006
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intra Cellular Therapies (NASDAQ:ITCI)
Historical Stock Chart
From Sep 2023 to Sep 2024